SMRTR summary
Chugai Pharmaceutical is adopting Phylo's Biomni Lab AI platform to support drug discovery across single-cell analysis, human genetics, disease biology, and target evaluation, making it one of the platform's first customers.
SMRTR provides this summary for quick context. The original article belongs to Unite AI.
Read the original articleThis archive is built from SMRTR newsletter stories. Subscribe for hand-picked stories without the extra noise.
SpaceX is building a second Starbase in Louisiana's Vermilion Parish, investing $100 billion with construction starting in 2027 and a first Starship launch planned for 2029.
NuScale Power's AI tool helps nuclear engineers find technical information up to 80% faster, using nuclear-specific terminology linked to verified sources to accelerate small...
Researchers at CU Boulder embedded "phononic subsurfaces" under aircraft skin to passively reduce turbulence and drag using microscopic vibrations. Two new breakthroughs enable...
WWI and WWII shipwrecks leaking toxic chemicals, including TNT byproducts, into the North Sea are contaminating marine life and threatening fisheries as pollutants move up the...
Colin Chu, 18, developed an ML and physics-based model that predicts EV battery health with just 2.36% error, validated on 22 aged batteries, potentially improving EV safety and...
Iveda's GX10-F100 is a gas-powered autonomous helicopter drone offering 150-minute flight time, 19-pound payload capacity, and 68 mph top speed, supporting military logistics,...